Where is Kaster located?

Kaster is headquartered in Montreal, Canada.

How many employees does Kaster have?

As of Sep 30, 2026, the latest employee count at Kaster is 13.

Is Kaster a funded company?

Kaster is a funded company, having raised a total of $***** in its 1st and only funding round, a Seed round on Feb 09, 2026.

When was the latest funding round of Kaster?

Kaster's latest funding was a $***** Seed round on Feb 09, 2026, with participation from 2 investors.

Where does Kaster rank among its competitors?

Kaster ranks 8th amongst 29 active competitors, of which 8 are funded. It stands 7th in terms of total funding among its competitors. The most recent competitor to raise funding was Numerion, which secured $19.8M in Mar, 2026.

Who are the top competitors of Kaster?

Kaster's top competitors include Etcembly, Promise and Apriori Bio. Among them, Numerion secured the most recent funding round in March, 2026.

Kaster - 2026 Company Profile, Funding & Competitors

Company Details

Developer of short-term production planning software for pharmaceutical manufacturers. The software aims to restore stability and on-time performance across shared resources. It synchronizes planning, cleanrooms, and support teams in real time. The software removes recurring slowdowns and improves flow across production stages. It enables proactive, data-driven actions instead of reactive firefighting. The software automatically respects rules, equipment constraints, and timing requirements. It continuously adjusts production plans down to the minute.

Key Metrics

Location

Montreal, Canada

Stage

Seed

Total Funding

$1.17M in 1 round

Latest Funding Round

Seed, Feb 09, 2026, $*****

Investors

Graphite Ventures & 1 more

Ranked

8^th among 29 active competitors

Employee Count

13 as on Sep 30, 2026

Similar Companies

Etcembly & 25 more

View Kaster's full profile

Kaster has raised a total funding of $1.17M over 1 round. Its latest funding round was a Seed round on Feb 09, 2026 for $*****. 2 investors participated in its latest round. Kaster has 2 institutional investors.

Here is the list of recent funding rounds of Kaster:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Feb 09, 2026	6638791	Seed	2685958	3613485	9317954	4450648

Access funding benchmarks and valuations. Sign up today!

View details of Kaster's funding rounds and investors

Kaster's employee count trend

Kaster has 13 employees as of Sep 26. Here is Kaster's employee count trend over the years:

Uncover Kaster's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Kaster include Etcembly, Promise and Apriori Bio. Here is the list of Top 10 competitors of Kaster, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Etcembly 2020, Harwell (United Kingdom), Series A	Developer of AI-driven technology for engineering and designing novel immunotherapies	$12.7M	-	57/100
2nd	Promise 2020, Tel Aviv (Israel), Seed	Provider of AI-based platform for personalised treatment plans	$8.3M	Awz Ventures, Pfizer & 2 others	56/100
3rd	Apriori Bio 2020, Belmont (United States), Seed	AI-based infection control and vaccine prediction tool for healthcare	$1.1M	CEPI, Flagship Pioneering	45/100
4th	Inceptive 2021, Palo Alto (United States), Series A	AI-based RNA molecular modeling tool for the vaccine	$120M	Andreessen Horowitz, Nvidia & 4 others	45/100
5th	Archon Bio 2023, Seattle (United States), Seed	Provider of computational platform to develop protein therapeutics	$20M	Madrona, Washington Research Foundation & 5 others	45/100
6th	OncoImmunity 2014, Oslo (Norway), Acquired	Developer of machine-learning based software for personalized cancer immunotherapy	$7.37M	EIC Fund, Radforsk & 2 others	45/100
7th	CellsBin 2022, New Haven (United States), Funding Raised	Developer of nanophotonic platforms for detecting and isolating rare cells	-	Connecticut Innovations	32/100
8th	Kaster Montreal (Canada), Seed	Developer of short-term production planning software for pharmaceutical manufacturers	$1.17M	Graphite Ventures, Hidden Layers	29/100
9th	Numerion 2012, San Francisco (United States), Series B	Developer of an AI platform for discovering novel drug-like molecules	$19.8M	-	28/100
10th	Neuromathix Brisbane (Australia), Unfunded	Decison support software to develop personalized healthcare model based on patient specific heath parameters	-	-	24/100